Alzheimer's Disease Trial, Recruiting NCT07364019 Sponsor: University of British Columbia Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07364019
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have completed the trial's electronic consent process
  • People with enough ability in English or French to take part in online assessments and an online education program
  • People who have regular access to a computer or tablet with an internet connection, can use a desktop or laptop at least once every 6 months, can send and receive emails, and are able to complete online assessments
  • People with sufficient vision to take part in an online education program and complete online cognitive tests
  • People between the ages of 50 and 80
  • People considered at increased risk of dementia due to at least one of the following: a parent or sibling who has had dementia; having completed high school (Grade 12) or less; or self-reporting at least one of the following — high blood pressure, high cholesterol, a body mass index over 30, or not being physically active (physical activity here means at least 20–30 minutes of exercise that causes sweating and breathlessness, at least twice a week)

Who may not be able to join:

  • People who have already been diagnosed with dementia (based on self-report)
  • People who are currently taking part in, or have previously taken part in, a study involving a program called BHPro

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 604-822-6379

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 May 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in modifiable risk factors as measured by a 7-item composite dementia risk factor score after 6 months.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov